RICHLAND, Wash., Sept. 28, 2021 (GLOBE NEWSWIRE) -- The American Brachytherapy Society (ABS) has recognized Isoray’s Cesium-131 in its recently released new consensus statement on the subject of low ...
Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR). Due to a lack of conclusive data, it still ...
Low-dose-rate brachytherapy is associated with excellent long-term biochemical control and survival, new study finds. Low-dose-rate brachytherapy (LDR-BT), primarily as a boost in conjunction with ...
Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR). Due to a lack of conclusive data, it still ...
Effect of PEDF on survival and the in vivo antitumor activities of low-dose chemotherapy in castration-refractory prostate cancer. Background: We report the outcomes for a cohort of men with higher ...
External-beam radiation therapy (EBRT) combined with brachytherapy is an attractive treatment option for selected patients with clinically localized prostate cancer. This therapeutic strategy offers ...
Post-Brachytherapy Erectile Function Preserved in Most Men Among men with low-risk prostate cancer, the likelihood of biochemical failure is lower among patients who undergo low-dose-rate ...
In contrast to low-dose-rate (LDR) brachytherapy, where radioactive seed implants are placed permanently in the body and gradually deposit low levels of radiation over a period of months, HDR ...
Lower urinary tract morbidity after prostate brachytherapy with cesium-131. Background: There is no consensus for the definition and evaluation of CTV in post-implant setting for LDR prostate ...
The optical fibre sensor can be placed within a brachytherapy needle for direct tumour dose monitoring. (Courtesy: Biomed. Opt. Express 10.1364/BOE.385610) Low-dose-rate (LDR) brachytherapy, in which ...
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario have issued a joint clinical practice guideline update on the use of brachytherapy for prostate cancer patients. Brachytherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results